As the Covid 19 quarantine measure continue, President Trump tweeted, “We will be, by mutual consent, temporarily closing our northern border with Canada.” He said trade would not be affected. However, many cannabis companies have operations in both countries.

Research suggests marijuana can help you fall asleep, but habitual use could lead to some problems.

The CBD industry is booming and shows signs of not going away anytime soon. While more and more businesses continue to incorporate the compound with differing levels of success, people continue to be as intrigued by CBD as ever, finding it accessible enough to want to incorporate it into their lives, be that for health or fun.

With this environment in mind, it’s important for employers to understand the compound and the benefits and hindrances it could provide for employees. Since CBD has connections with marijuana and the legality of that topic remains complex, it’s best if employers are just as informed as users who consume the compound. Here are 5 things employers should know about CBD:

There are over 500,000 Google scholarly articles on CBD and millions of Instagram photos tagging the hyper-popular compound.

Social media is a hot spot for wellness trends and recommendations. According to new research, CBD is the most posted about trend with the most substantial amount of research behind it, at least according to the internet.

According to a marijuana testing lab in San Diego, almost 80% of the unregulated cannabis vape cartridges they tested were deemed “unfit for consumption”, reports ABC10 News.

Platinum Vape manufacturing company produces high-potency, pesticide-free cannabis products that go through rigorous testing, reports ABC10. Co-founder George Sadler is on a mission to spread awareness about the serious potential health risks of using products from unlicensed vape makers and sellers.

The coronavirus has had a big impact on the world’s economy, and even more so on the financial cannabis market. While the S&P Index has seen a 17% drop, various marijuana companies have experienced a drop of 30% and more. Of course, this raises the question of whether it’s a good time to buy cannabis stocks right now, and if there’s any chance of finding a bargain.

A communal smoke session, whether it be at a social event with strangers or with your closest confidants, is an amazing experience for several reasons. It sparks laughter, deep conversation, and ultimately creates a bond between like-minded people. But truth be told, depending on your view of germs, it can also be pretty disgusting.  

As legalization breaks the long-held stigma surrounding cannabis consumption, more people are starting to warm up to the benefits of this multifaceted plant. One aspect of smoking cannabis that usually goes unexamined, however, is the germ exchange that comes with sharing a bong or passing a joint. 

Batten down the hatches, because volatility has returned in a big way for the stock market. Over a 12-session stretch, ending this past Tuesday, March 10, the 123-year-old Dow Jones Industrial Average logged its three biggest single-day point gains in history, as well as six of its 11 largest single-day point drops of all time.

If you're a short-term trader, these moves have been nauseating. But if you're a buy-and-hold investor, this volatility has been an opportune time to buy great businesses on the cheap.

The nation's rapid shift into social distancing and isolation has been lousy for most segments of the U.S. economy, but one niche seeing significant growth in recent days is the licensed cannabis sector, home to companies like Curaleaf (OTC:CURLF), and Cresco Labs (OTC:CRLBF).